| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |